US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 1.5400
  • +0.0400+2.67%
Close Mar 26 16:00 ET
  • 1.5400
  • 0.00000.00%
Post 20:01 ET
6.25MMarket Cap-0.23P/E (TTM)

About NLS Pharmaceutics Company

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

Company Profile

SymbolNLSP
Company NameNLS Pharmaceutics
Listing DateJan 29, 2021
Issue Price4.15
Founded2015
CEOMr. Alexander Zwyer
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
AddressThe Circle 6
CityZurich
ProvinceZurich
CountrySwitzerland
Zip Code8058
Phone41-44-512-21-50
Websitehttp://www.nlspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Alexander Zwyer
  • Chief Executive Officer and Director
  • --
  • Elena Thyen-Pighin
  • Chief Financial Officer and Head of Finance and Human Resources
  • --
  • George Apostol
  • Chief Medical Officer and Global Head of Research and Development
  • --
  • Dr. Eric Konofal, M.D.
  • Chief Scientific Officer
  • --
  • Ronald Hafner
  • Chairman of the Board
  • --
  • Audrey Greenberg
  • Independent Director
  • --
  • Gian-Marco Rinaldi
  • Independent Director
  • --
  • Florence Allouche Aknin
  • Independent Director
  • --
  • Claudio L. A. Bassetti
  • Independent Director
  • --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
KB Home
KBH
+0.92%
Ecopetrol
EC
+0.87%
Petroleo Brasileiro SA Petrobras
PBR
+0.42%
Vale SA
VALE
+0.40%
Taylor Morrison Home
TMHC
+0.12%

Unlock the Full List